Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

Certain hormones can reduce skin oil and hair growth, potentially helping treat acne and excessive hair in women.

The conclusion is that tritium-labeled testosterone metabolites can be made and are better converted into dihydrotestosterone in skin cells than in prostate tissue.

Different types of androgens bind differently to two receptors, AR1 and AR2, in Atlantic croaker's brain and ovarian tissues, suggesting these receptors may control different androgen actions in fish.

Biochanin A from soy is a promising and safe candidate for treating hair loss.

The compound was successfully made and shows potential for treating prostate cancer.

New progesterone-based compounds can block male hormones.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

Some steroid-induced health issues in rodents improved after stopping treatment, but hair loss and eye problems did not.

Norethisterone (jenapharm) therapy is effective for endometrial cancer.

The method is quick and effective for testing steroid 5 alpha-reductase inhibitors.

Girard's reagent P improves detection of spironolactone and its metabolites.

Combining 5α-reductase and aromatase inhibitors may better reduce estrogen levels.

Biochanin A from soy is a promising and safe candidate for treating hair loss.

The new LC-MS/MS method is more accurate and reliable than traditional immunoassays for measuring steroids in serum.

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

Finasteride blocks progesterone production in specific tumor cells, potentially causing side effects.

Natural herbal compounds might treat certain medical conditions by reducing DHT levels, but more research is needed to confirm their effectiveness and safety.

Finasteride and dutasteride both improve hair growth effectively, but dutasteride has stronger anti-androgen effects and finasteride may cause more sexual side effects.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Human adrenals and gonads have a unique enzyme for steroid hormone production.

Women with androgenetic alopecia have normal levels of most blood steroids and binding proteins, but higher dehydroepiandrosterone. Some also have low "sex hormone-binding globulin" and "corticosteroide-binding globulin" capacity, and high "free androgen index" and "free cortisol index". Diane treatment can normalize these levels and improve hair conditions.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, and antioxidants may help treat hair loss.

Acne severity is linked to higher levels of certain androgenic hormones, even when those levels are within the normal range.

More body hair in young Australian women is linked to higher androstenedione levels.